These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 8806472
1. Allogeneic lymphocyte responses to B7-1 expressing human cancer cell lines. Dessureault S, Gallinger S. J Surg Res; 1996 Jul 15; 64(1):42-8. PubMed ID: 8806472 [Abstract] [Full Text] [Related]
2. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines. Fenton RG, Turcovski-Corrales SM, Taub DD. J Immunother; 1998 Mar 15; 21(2):95-108. PubMed ID: 9551360 [Abstract] [Full Text] [Related]
3. Expression of a variant of CD28 on a subpopulation of human NK cells: implications for B7-mediated stimulation of NK cells. Galea-Lauri J, Darling D, Gan SU, Krivochtchapov L, Kuiper M, Gäken J, Souberbielle B, Farzaneh F. J Immunol; 1999 Jul 01; 163(1):62-70. PubMed ID: 10384100 [Abstract] [Full Text] [Related]
4. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line. Azuma M, Cayabyab M, Buck D, Phillips JH, Lanier LL. J Immunol; 1992 Aug 15; 149(4):1115-23. PubMed ID: 1380031 [Abstract] [Full Text] [Related]
5. Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells. Dessureault S, Graham FL, Gallinger S. Cancer Gene Ther; 1999 Aug 15; 6(3):195-208. PubMed ID: 10359205 [Abstract] [Full Text] [Related]
12. CD80 transfected human hepatocellular carcinoma cells activate cytotoxic T lymphocytes to target HCC cells with shared tumor antigens. Chan RC, Xie Y. Oncol Rep; 2004 Aug 15; 12(2):435-42. PubMed ID: 15254713 [Abstract] [Full Text] [Related]
13. Expression of CD80 enhances immunogenicity of cervical carcinoma cells in vitro. Kaufmann AM, Gissmann L, Street D, Schreckenberger C, Hunter M, Qiao L. Cell Immunol; 1996 May 01; 169(2):246-51. PubMed ID: 8620552 [Abstract] [Full Text] [Related]
14. Human tumor antigen-specific T lymphocytes and interleukin-2-activated natural killer cells: comparisons of antitumor effects in vitro and in vivo. Whiteside TL, Sung MW, Nagashima S, Chikamatsu K, Okada K, Vujanovic NL. Clin Cancer Res; 1998 May 01; 4(5):1135-45. PubMed ID: 9607570 [Abstract] [Full Text] [Related]
15. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor. Chan AK, Goedegebuure PS, von Bernstorff W, Carritte AL, Chung M, Stewart RA, Montgomery L, Spanjaard RA, McKenzie AB, Eberlein TJ. Surgery; 2000 Mar 01; 127(3):342-50. PubMed ID: 10715992 [Abstract] [Full Text] [Related]
16. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, gamma delta T cells, and antigen-specific CTL. Bakker AB, Phillips JH, Figdor CG, Lanier LL. J Immunol; 1998 Jun 01; 160(11):5239-45. PubMed ID: 9605119 [Abstract] [Full Text] [Related]
17. Therapeutic antitumor response to cervical cancer in mice immunized with U14 vaccines transfected with costimulatory B7 gene. Tao G, Hu J, Zou H, Lin Q, Liu F, Wu Y, Sun Q. Chin Med J (Engl); 2001 Jun 01; 114(6):623-7. PubMed ID: 11780440 [Abstract] [Full Text] [Related]